Cancer Supportive Care Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Price: 3200/- USD | Published Date: October 30, 2020 |

The global cancer supportive care market size is projected to grow at a significant CAGR of 5.06% market during 2020-2027. Supportive care is of critical importance in cancer management. Prevention of conditions such as anemia, mucosal injuries, cardiovascular toxicity, bone metastases, etc. holds important positions in cancer treatment and management and clear guidelines have already been put in place to achieve desired and optimum treatment outcomes in order to contain cancer mortality. As cancer prevalence is perpetually growing, there has been a simultaneous evolution of treatments such as radiation therapy ad chemotherapy. However, the emergence of such cytotoxic treatments has brought in tow rise to side effects that majorly interfere with overall treatment outcome and patient wellbeing. This phenomenon has resulted in the introduction of cancer supportive treatments with an intention to improve the overall treatment outcome.

Market Insights:

As the global prevalence of cancer is continuously growing, there has been a corresponding rise in methods of cancer care, which has led to the evolution of treatments like radiation therapy and chemotherapy. However, evolution of such cytotoxic treatments has also brought with itself a host of side effects that greatly interfere with the overall treatment outcome and patient wellbeing. This phenomenon has led to the emergence of supportive acre drugs that assist in controlling and managing debilitating side effects such as anemia, neutropenia, nausea, and vomiting, etc.

Perpetual growth in the incidence of cancer is observed to be the major driver of the cancer supportive care market. Furthermore, the introduction of novel and more potent cancer drugs has presented with them a range of side effects that interfere with seamless treatment management and overall patient wellbeing. Other factors such as growth in awareness among both patients and healthcare staff and evolving reimbursement system will open further opportunities in this market.

Market Segment Insights:

The global cancer supportive care market, for the purpose of this report, is studied in terms of therapeutic area, cancer type, sales channel, and geography. Based on therapeutic areas, the cancer supportive care market is studied for oral mucositis and dry mouth, chemotherapy-induced nausea and vomiting, cancer pain, chemotherapy-induced anemia, chemotherapy-induced neutropenia, and bone metastases. This report further classifies the cancer supportive care market in terms of major cancer types namely, lung cancer, liver cancer, breast cancer, leukemia, prostate cancer, ovarian cancer, bladder cancer, and others. Hospital pharmacies, retail pharmacies, and compounding pharmacies are the prime sales channels considered in this study.

Global Cancer Supportive Care Market Segmentation:

By Therapeutic Area, 2018–2027 ($ Millon)

  • Oral Mucositis and Dry Mouth
  • Chemotherapy-induced Nausea and Vomiting
  • Cancer Pain
  • Chemotherapy Induced Anemia
  • Chemotherapy Induced Neutropenia
  • Bone Metastases

By Cancer Type, 2018–2027 ($ Millon)

  • Lung Cancer
  • Liver Cancer
  • Breast Cancer
  • Leukemia
  • Prostate Cancer
  • Ovarian Cancer
  • Bladder Cancer
  • Others

By Sales Channel, 2018–2027 ($ Millon)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Compounding Pharmacies

By Geography, 2018-2027 ($ Millon)

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Regional Insights:

For the purpose of this study, the global cancer supportive care market is regionally categorized into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa markets. These regional markets are further sub-segmented into top country-level markets that majorly determine the regional industry trends. Currently, North America and Europe together occupy the largest revenue share of the global cancer supportive care market. Evolved reimbursement systems and greater incidence of cancer are the key factors contributing to the dominance of these regions. On the other hand, Asia Pacific is expected to be the fastest-growing regional market for cancer supportive care drugs.

Market Competition Assessment:

The major players currently operating in the global cancer supportive care market include Amgen, Inc., Novartis AG, Johnson & Johnson, Pfizer, Teva Pharmaceutical Industries Ltd., and others.

List of Key Companies:

  • Amgen Inc.
  • Novartis AG
  • Johnson & Johnson
  • Pfizer
  • Teva Pharmaceutical Industries Ltd.
  • Hoffmann-La Roche Ltd.
  • Baxter International Inc.
  • Fagron Group BV
  • Helsinn Group
  • Acacia Pharma Ltd.

To know more about this study, request a free report sample @ https://www.researchcorridor.com/request-sample/?id=73420

Key Questions Answered by Cancer Supportive Care Market Report

  • Global cancer supportive care market forecasts from 2020-2027
  • Regional cancer supportive care market forecasts from 2020-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
  • Country-level forecasts from 2020-2027 covering 15 major countries from the aforementioned regions
  • Cancer Supportive Care submarket forecasts from 2020-2027 covering the market by therapeutic area, by cancer type, by sales channel, and geography
  • Various industry models such as SWOT analysis, Pestle Analysis, Porter’s Five Force model, Value Chain Analysis pertaining to cancer supportive care market
  • Analysis of the key factors driving and restraining the growth of the global, regional, and country-level cancer supportive care markets from 2020-2027
  • Competitive Landscape and market positioning of top 10 players operating in the cancer supportive care market

(Reports will be updated due to COVID-19 impacts on the market)

Request Report Sample
Inquiry Before Buying

Table of Content:


Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Cancer Supportive Care Market Portraiture
2.2 Global Cancer Supportive Care Market, by Therapeutic Area, 2019 ($ Million)
2.3 Global Cancer Supportive Care Market, by Cancer Type, 2019 ($ Million)
2.4 Global Cancer Supportive Care Market, by Sales Channel, 2019 ($ Million)
2.5 Global Cancer Supportive Care Market Share, by Geography, 2019 (Value %)
Chapter 3 Global Cancer Supportive Care Market Overview
3.1 Overview
3.2 Major Drug Classes Assessment
3.2.1 Anti-infectives
3.2.2 Anti-emetics
3.2.3 Biophosphonates
3.2.4 Granulocyte Stimulating Agents
3.2.5 Erythropoietin Stimulating Agents
3.2.6 Opioid Analgesics
3.2.7 NSAIDS
3.2.8 Monoclonal Antibodies
3.3 Market Dynamics
3.3.1 Drivers
3.3.2 Challenges
3.3.3 Opportunities
3.4 Attractive Investment Proposition
3.5 Market Competition Assessment: Cancer Supportive Care Market, by Key Players
Chapter 4 Global Cancer Supportive Care Market, by Therapeutic Area, 2018-2027 ($ Million)
4.1 Introduction
4.2 Oral Mucositis and Dry Mouth
4.3 Chemotherapy Induced Nausea and Vomiting
4.4 Cancer Pain
4.5 Chemotherapy Induced Anemia
4.6 Chemotherapy Induced Neutropenia
4.7 Bone Metastases
Chapter 5 Global Cancer Supportive Care Market, by Cancer Type, 2018-2027 ($ Milllion)
5.1 Introduction
5.2 Lung Cancer
5.3 Liver Cancer
5.4 Breast Cancer
5.5 Leukemia
5.6 Prostate Cancer
5.7 Ovarian Cancer
5.8 Bladder Cancer
5.9 Others
Chapter 6 Global Cancer Supportive Care Market, by Sales Channel, 2018-2027 ($ Million)
6.1 Introduction
6.2 Hospital Pharmacies
6.3 Retail Pharmacies
6.4 Compounding Pharmacies
Chapter 7 Global Cancer Supportive Care Market, by Geography, 2018-2027 ($ Million)
7.1 Preface
7.2 North America (U.S., Canada)
7.3 Europe (U.K., Germany, Rest of Europe)
7.4 Asia Pacific (Japan, China, Australia, Rest of Asia Pacific)
7.5 Latin America (Brazil, Mexico, Rest of LATAM)
7.6 Middle East and Africa (Saudi Arabia, South Africa, Rest of MEA)
Chapter 8 Company Profiles
8.1 Amgen Inc.
8.2 Novartis AG
8.3 Johnson & Johnson
8.4 Pfizer
8.5 Teva Pharmaceutical Industries Ltd.
8.6 F. Hoffmann-La Roche Ltd.
8.7 Baxter International Inc.
8.8 Fagron Group BV
8.9 Helsinn Group
8.10 Acacia Pharma Ltd.
Fill the given form to inquiry before buying for Cancer Supportive Care Market Report

Your Designtaion (required):

Select License Type
$3200/- Single User License
$4800/- Multi User License
$6400/- Corporate License

Why To Choose Us:
  • Markets in over 150 countries analyzed granularly
  • 35% of our total client base has an annual subscription membership
  • 24x7 availability we are always there when you need us
  • 100,000+ data points in our comprehensive database
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report
  • We focus on the accuracy and quality of the report
  • Our analyst will provide deep insights into the report
For Any Assitance
Call Us: +919893685690
Contact Person: Mr. Vijendra Singh
Contact Email: sales@researchcorridor.com